Drug Profile
IPR 8501
Latest Information Update: 06 Jun 2001
Price :
$50
*
At a glance
- Originator Institute for Pharmaceutical Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alopecia
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Alopecia in Switzerland (Topical)
- 25 May 1998 Preclinical development for Alopecia in Switzerland (Topical)